Biogenic monoamines are crucial for various bodily functions and are stored in secretory vesicles by vesicular monoamine transporters (VMATs) for controlled release. VMATs use proton antiport to enrich monoamines and protect neurons from neurotoxicants. Therapeutic drugs target VMATs to treat neurodegenerative disorders, hypertension, and drug addiction. Cryo-electron microscopy structures of human VMAT1 reveal insights into its binding with different compounds, shedding light on the mechanism of vesicular monoamine transport.
To Another Language
from source content
www.nature.com
Key Insights Distilled From
by Jin Ye,Huapi... at www.nature.com 03-18-2024
https://www.nature.com/articles/s41586-024-07290-7Deeper Inquiries